284 related articles for article (PubMed ID: 22101407)
21. Long-term genistein treatment of MCF-7 cells decreases acetylated histone 3 expression and alters growth responses to mitogens and histone deacetylase inhibitors.
Jawaid K; Crane SR; Nowers JL; Lacey M; Whitehead SA
J Steroid Biochem Mol Biol; 2010 Jun; 120(4-5):164-71. PubMed ID: 20399854
[TBL] [Abstract][Full Text] [Related]
22. G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression.
Zhang X; Peng D; Xi Y; Yuan C; Sagum CA; Klein BJ; Tanaka K; Wen H; Kutateladze TG; Li W; Bedford MT; Shi X
Nat Commun; 2016 Mar; 7():10810. PubMed ID: 26960573
[TBL] [Abstract][Full Text] [Related]
23. SUV420H2 suppresses breast cancer cell invasion through down regulation of the SH2 domain-containing focal adhesion protein tensin-3.
Shinchi Y; Hieda M; Nishioka Y; Matsumoto A; Yokoyama Y; Kimura H; Matsuura S; Matsuura N
Exp Cell Res; 2015 May; 334(1):90-9. PubMed ID: 25814362
[TBL] [Abstract][Full Text] [Related]
24. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism].
Rahimian A; Barati G; Mehrandish R; Mellati AA
Mol Biol (Mosk); 2018; 52(3):474-481. PubMed ID: 29989579
[TBL] [Abstract][Full Text] [Related]
25. Histone modifying enzymes: novel disease biomarkers and assay development.
Ma F; Zhang CY
Expert Rev Mol Diagn; 2016; 16(3):297-306. PubMed ID: 26750583
[TBL] [Abstract][Full Text] [Related]
26. Histone lysine trimethylation or acetylation can be modulated by phytoestrogen, estrogen or anti-HDAC in breast cancer cell lines.
Dagdemir A; Durif J; Ngollo M; Bignon YJ; Bernard-Gallon D
Epigenomics; 2013 Feb; 5(1):51-63. PubMed ID: 23414320
[TBL] [Abstract][Full Text] [Related]
27. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
Sharma M; Tollefsbol TO
Exp Cell Res; 2022 Jul; 416(1):113160. PubMed ID: 35447103
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells.
Yu SL; Lee DC; Son JW; Park CG; Lee HY; Kang J
Oncol Rep; 2013 Sep; 30(3):1293-300. PubMed ID: 23817620
[TBL] [Abstract][Full Text] [Related]
29. Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.
Messier TL; Gordon JA; Boyd JR; Tye CE; Browne G; Stein JL; Lian JB; Stein GS
Oncotarget; 2016 Feb; 7(5):5094-109. PubMed ID: 26783963
[TBL] [Abstract][Full Text] [Related]
30. Aberrant histone acetylation and methylation levels in woman with endometriosis.
Xiaomeng X; Ming Z; Jiezhi M; Xiaoling F
Arch Gynecol Obstet; 2013 Mar; 287(3):487-94. PubMed ID: 23080547
[TBL] [Abstract][Full Text] [Related]
31. Abnormal histone modification patterns in lupus CD4+ T cells.
Hu N; Qiu X; Luo Y; Yuan J; Li Y; Lei W; Zhang G; Zhou Y; Su Y; Lu Q
J Rheumatol; 2008 May; 35(5):804-10. PubMed ID: 18398941
[TBL] [Abstract][Full Text] [Related]
32. Novel histone deacetylase 8-selective inhibitor 1,3,4-oxadiazole-alanine hybrid induces apoptosis in breast cancer cells.
Pidugu VR; Yarla NS; Bishayee A; Kalle AM; Satya AK
Apoptosis; 2017 Nov; 22(11):1394-1403. PubMed ID: 28840369
[TBL] [Abstract][Full Text] [Related]
33. A dual role for the histone methyltransferase PR-SET7/SETD8 and histone H4 lysine 20 monomethylation in the local regulation of RNA polymerase II pausing.
Kapoor-Vazirani P; Vertino PM
J Biol Chem; 2014 Mar; 289(11):7425-37. PubMed ID: 24459145
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic Modifications with DZNep, NaBu and SAHA in Luminal and Mesenchymal-like Breast Cancer Subtype Cells.
Dagdemir A; Judes G; Lebert A; Echegut M; Karsli-Ceppioglu S; Rifaï K; Daures M; Ngollo M; Dubois L; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
Cancer Genomics Proteomics; 2016; 13(4):291-303. PubMed ID: 27365379
[TBL] [Abstract][Full Text] [Related]
35. SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancer.
Viotti M; Wilson C; McCleland M; Koeppen H; Haley B; Jhunjhunwala S; Klijn C; Modrusan Z; Arnott D; Classon M; Stephan JP; Mellman I
J Cell Biol; 2018 Feb; 217(2):763-777. PubMed ID: 29229751
[TBL] [Abstract][Full Text] [Related]
36. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells.
Tryndyak VP; Beland FA; Pogribny IP
Int J Cancer; 2010 Jun; 126(11):2575-83. PubMed ID: 19839049
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells.
Huang Y; Vasilatos SN; Boric L; Shaw PG; Davidson NE
Breast Cancer Res Treat; 2012 Feb; 131(3):777-89. PubMed ID: 21452019
[TBL] [Abstract][Full Text] [Related]
38. Relationship between lunasin's sequence and its inhibitory activity of histones H3 and H4 acetylation.
Hernández-Ledesma B; Hsieh CC; de Lumen BO
Mol Nutr Food Res; 2011 Jul; 55(7):989-98. PubMed ID: 21618425
[TBL] [Abstract][Full Text] [Related]
39. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
[TBL] [Abstract][Full Text] [Related]
40. Cancer-associated upregulation of histone H3 lysine 9 trimethylation promotes cell motility in vitro and drives tumor formation in vivo.
Yokoyama Y; Hieda M; Nishioka Y; Matsumoto A; Higashi S; Kimura H; Yamamoto H; Mori M; Matsuura S; Matsuura N
Cancer Sci; 2013 Jul; 104(7):889-95. PubMed ID: 23557258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]